Drug Profile
Salmeterol/fluticasone propionate - Hanmi Pharmaceutical
Alternative Names: Fluterol; HCP-0910Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class Androstadienes; Antiallergics; Antiasthmatics; Bronchodilators; Ethanolamines; Glucocorticoids; Phenethylamines; Small molecules
- Mechanism of Action Arachidonic acid inhibitors; Beta 2 adrenergic receptor agonists; Glucocorticoid receptor agonists; Lipocortin synthesis agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
Most Recent Events
- 22 Apr 2014 Launched for Asthma in South Korea (Inhalation)
- 01 Jul 2013 Hanmi Pharmaceutical completes its phase I trial in Asthma in South Korea (NCT01521455)
- 01 Feb 2012 Phase-I clinical trials in Asthma in South Korea (Inhalation)